The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies

Journal of Clinical Virology

Volumn 12, Issue 3, 1999, Pages 243-252

  Levi, M ^a   Ruden U ^a   Carlberg, H ^b   Wahren, B ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Enzyme immunoassay; Glycoprotein D; Glycoprotein G; Herpes simplex virus; Peptides; Western blot

Indexed keywords

CROSS REACTING ANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN D; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN G; PEPTIDE; SYNTHETIC PEPTIDE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN EXPERIMENT; IMMUNE STATUS; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; VIRUS CHARACTERIZATION; VIRUS INFECTION; WESTERN BLOTTING;

EID: 0033046777     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(98)00065-1     Document Type: Article

References (23)

1. al-Ahdal MN Glycoprotein variability in herpes simplex virus type 1 strains by radioimmunoprecipitation with monoclonal antibodies. Microbios. 74:1993;95-102.
2. Ashley RL, Militoni J, Lee F, Nahmias A., Corey L Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 26:1988;662-667.
3. Ashley RL Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med. 69:1993;174-183.
4. Balachandran N, Hutt-Fletcher LM Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J Virol. 54:1985;825-832.
5. Bergström T, Vahlne A, Alestig K, Forsgren M, Lycke E Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis. 162:1990;322-330.
6. Christenson B, Böttiger M, Svensson Å, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infec. 1992;25:147-154.
7. Farkkila M, Koskiniemi M, Vaheri A Clinical spectrum of neurological herpes simplex infection. Acta Neurol Scand. 87:1993;325-328.
8. Field PR, Ho DWT, Irving WL, Isaacs D, Cunningham AL The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology. 25:1993;175-179.
9. Geerligs HJ, Feijlbrief M, Bolk M et al. Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D. Arch Virol. 114:1990;251-258.
10. Henry KS, Fetherston JD, Smith ME, Courtney RJ Orientation of the cleavage site of the herpes simplex virus glycoprotein G-2. J Virol. 67:1993;2954-2959.
11. Ho DWT, Field PR, Sjögren-Jansson E, Jeansson S, Cunningham AL Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods. 36:1992;249-264.
12. Ho DWT, Field PR, Irving WL, Packham DR, Cunningham AL Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol. 31:1993;3157-3164.
13. Kinghorn GR. Epidemiology of genital herpes. J Int Med Res 1994;1 Suppl 22:14A-23A.
14. Levi M, Rudén U, Wahren B Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagnost Lab Immunol. 3:1996;265-269.
15. McGeoch DJ, Dolan A, Donald S, Rixon FJ Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol. 181:1985;1-13.
16. McGeoch DJ, Moss HWM, McNab D, Frame MC DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G and evolutionary comparisons. J Gen Virol. 68:1987;19-38.
17. Oliver L, Wald A, Kim M et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med. 4:1995;228-232.
18. Olofsson S, Lundström M, Marsden H, Jeansson S, Vahlne A Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J Gen Virol. 67:1986;737-744.
19. Shev S, Widell A, Bergström T, Hermodsson S, Lindholm A, Norkrans G Herpes simplex virus-2 may increase susceptibility of the sexual transmission of hepatitis C. Sex Transm Dis. 22:1995;210-216.
20. Straus SE, Wald A, Kost RG et al. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Inf Dis. 176:1994;1129-1134.
21. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol. 19:1984;235-239.
22. Wald A, Zeh J, Selke S Virologic characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med. 333:1995;770-775.
23. Whitley R, Arvin A, Prober C et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections: The national institute of allergy and infectious diseases collaborative antiviral study group. New Engl J Med. 324:1991;450-454.